Crossmark

Predictive factors for the efficacy of denosumab in postmenopausal Japanese women with non-metastatic breast cancer receiving adjuvant aromatase inhibitors: a combined analysis of two prospective clinical trials

Crossref DOI link: https://doi.org/10.1007/s00774-018-00985-8

Published Online: 2019-03-13

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakatsukasa, Katsuhiko

Koyama, Hiroshi

Ouchi, Yoshimi

Sakaguchi, Kouichi

Fujita, Yoshifumi

Matsuda, Takayuki

Kato, Makoto

Konishi, Eiichi

Taguchi, Tetsuya
License Information

Text and Data Mining valid from 2019-03-13
More Information

Article History

Received: 7 September 2018

Accepted: 19 December 2018

First Online: 13 March 2019

Compliance with ethical standards

:

: All authors declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below